Syra Health Corp financial data

Symbol
SYRA on OTC
Location
Carmel, IN
Fiscal year end
31 December
Latest financial report
10-K - Q4 2025 - 12 Mar 2026

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 322% % -23%
Debt-to-equity 44% % 25%
Return On Equity -39% % 69%
Return On Assets -27% % 71%
Operating Margin -13% % 73%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 11,339,169 shares 0.24%
Entity Public Float $979,537 USD
Weighted Average Number of Shares Outstanding, Basic 11,852,347 shares 57%
Weighted Average Number of Shares Outstanding, Diluted 11,852,347 shares 57%

Income Statement

Label TTM Value / Value Unit Change %
Revenues $7,225,973 USD -9.5%
Revenue from Contract with Customer, Excluding Assessed Tax $7,225,973 USD -9.5%
Research and Development Expense $67,840 USD -88%
Operating Income (Loss) $904,324 USD 76%
Nonoperating Income (Expense) $7,991 USD 42%
Net Income (Loss) Attributable to Parent $896,333 USD 76%
Earnings Per Share, Basic -0.08 USD/shares 84%
Earnings Per Share, Diluted -0.08 USD/shares 84%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value $1,614,733 USD -33%
Accounts Receivable, after Allowance for Credit Loss, Current $918,374 USD 35%
Other Assets, Current $205,423 USD -26%
Assets, Current $2,738,530 USD -18%
Property, Plant and Equipment, Net $6,986 USD -74%
Operating Lease, Right-of-Use Asset $27,401 USD -91%
Assets $2,772,917 USD -25%
Accounts Payable, Current $557,056 USD 11%
Accrued Liabilities, Current $194,821 USD -15%
Liabilities, Current $674,739 USD 10%
Operating Lease, Liability, Noncurrent $187,212 USD
Liabilities $674,739 USD -16%
Retained Earnings (Accumulated Deficit) $9,720,526 USD -10%
Stockholders' Equity Attributable to Parent $2,098,178 USD -27%
Liabilities and Equity $2,772,917 USD -25%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities $158,231 USD
Net Cash Provided by (Used in) Financing Activities $63,051 USD -108%
Net Cash Provided by (Used in) Investing Activities $5,619 USD 42%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect $95,180 USD
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $1,614,733 USD -33%
Interest Paid, Excluding Capitalized Interest, Operating Activities $3,229 USD -21%
Deferred Tax Assets, Valuation Allowance $2,091,303 USD 10%
Deferred Tax Assets, Gross $2,091,303 USD 10%
Operating Lease, Liability $27,401 USD -91%
Depreciation $20,468 USD -67%
Payments to Acquire Property, Plant, and Equipment $5,619 USD -42%
Lessee, Operating Lease, Liability, to be Paid $27,900 USD -92%
Operating Lease, Liability, Current $27,401 USD -76%
Lessee, Operating Lease, Liability, to be Paid, Year Two $134,505 USD
Lessee, Operating Lease, Liability, to be Paid, Year One $27,900 USD -79%
Operating Lease, Weighted Average Discount Rate, Percent 0.0725 pure -22%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount $499 USD -99%
Lessee, Operating Lease, Liability, to be Paid, Year Three $67,252 USD
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 10,000,000 shares 0%
Additional Paid in Capital $11,806,765 USD 0.97%
Preferred Stock, Shares Outstanding 0 shares
Interest Expense $3,229 USD -21%
Preferred Stock, Par or Stated Value Per Share 0.001 USD/shares 0%